Related Experiment Video
Updated: Mar 28, 2026
Global Identification of Co-Translational Interaction Networks by Selective Ribosome Profiling
Published on: October 7, 2021
Genomic Databases and Biobanks in Israel
1Professor of Law at the University of Virginia School of Law and the Director of the Center for Health Law, Bioethics and Health Policy at Ono Academic College in Israel. He is a Member of the Israeli National Committee on Human Subject Research and Commissioner of the Israel National Bioethics Council. He earned his medical and law degrees from Tel Aviv University and doctorate degree in law from the University of Virginia.
Israel is developing its national biobank, MIDGAM, to advance medical research and commercial opportunities. This initiative requires a supportive social, legal, and regulatory environment, alongside scientific expertise and infrastructure.
Area of Science:
- Biomedical Research
- Biobanking
- Public Health Policy
Background:
- Large-scale biobanks offer significant scientific, medical, and commercial potential.
- Establishing biobanks necessitates a favorable social, legal, and regulatory climate, robust scientific communities, and adequate infrastructure.
- Israel's approach to creating a national biobank involves complex societal, ethical, and governmental considerations.
Purpose of the Study:
- To examine the factors influencing the establishment of the Israeli National Biobank, MIDGAM.
- To analyze the social, legal, and regulatory debates surrounding biobanking in Israel.
- To understand the interplay of civic engagement and scientific capacity in shaping national health initiatives.
Main Methods:
- Review of policy documents and governmental discussions.
- Analysis of social norms and public engagement related to biobanking.
- Exploration of the scientific and infrastructural requirements for a national biobank.
Main Results:
- The formulation of MIDGAM is shaped by ongoing debates on governance, structure, finance, and operational models.
- Social norms, civic engagement, and scientific capabilities are critical in guiding Israel's governmental response to medical needs.
- The Israeli context highlights the challenges and opportunities in establishing large-scale biobanks.
Conclusions:
- The development of MIDGAM reflects a complex negotiation between scientific aspirations, commercial interests, and societal values.
- Successful biobanking initiatives depend on a multi-faceted approach addressing scientific, ethical, and logistical challenges.
- Understanding the Israeli experience provides insights into the broader global efforts to leverage biobanks for medical advancement.
